Chantilly Bio Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
as on 03-12-2024
- Paid Up Capital ₹ 1.17 M
as on 03-12-2024
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -23.69%
(FY 2017)
- Profit -120.87%
(FY 2017)
- Ebitda 165.77%
(FY 2017)
- Net Worth -75.86%
(FY 2017)
- Total Assets 111.59%
(FY 2017)
About Chantilly Bio Pharma
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.17 M, as per Ministry of Corporate Affairs (MCA) records.
Kanaka Durga, Cherukuri Rao, and Nagajyothi Balusu serve as directors at the Company.
- CIN/LLPIN
U74999TG2011PTC075331
- Company No.
075331
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chantilly Bio Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Cherukuri Rao  | Managing Director | 06-Apr-2015 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanaka Durga  | Director | 04-Jul-2011 | Current |
| Nagajyothi Balusu | Director | 08-Jun-2019 | Current |
Financial Performance of Chantilly Bio Pharma.
Chantilly Bio Pharma Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 23.69% decrease. The company also saw a substantial fall in profitability, with a 120.87% decrease in profit. The company's net worth observed a substantial decline by a decrease of 75.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chantilly Bio Pharma?
In 2017, Chantilly Bio Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chantilly Bio Pharma?
Unlock and access historical data on people associated with Chantilly Bio Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chantilly Bio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chantilly Bio Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
